Neoadjuvant Therapy in TRIPle Negative Breast Cancer With antiPDL1 (NeoTRIPaPDL1)

Clinical Trial ID NCT02620280

PubWeight™ 2.81^‹?›

🔗 Visit the ClinicalTrials.gov page for NCT02620280

Top papers